Figure 7

Five-year disease-free survival (DFS) in African-American and Latina patients with either high or low pAkt together with their HER2/neu status. Kaplan-Meier survival curves were used to compare the 5-year DFS among patients with low pAkt/HER2^- (I, red), low pAkt/HER2⁺ (II, blue), high pAkt/HER2^- (III, fuchsia), and high pAkt/HER2⁺ (IV, green). The differences between the curves were estimated by log-rank test, and a p value of less than 0.05 was considered statistically significant. *p < 0.005, the indicated groups compared to group IV (high pAkt/HER2⁺). ^p = 0.03, between the indicated two groups.